MarketCap
Rafael Holdings RFL
€ 0.99
-1.77%
Facebook
X
Telegram
Rafael Holdings EV/EBITDA | RFL
EV/EBITDA Jährlich Rafael Holdings
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.45 | -0.0829 | -0.388 | -1.38 | -0.503 | -2.19 | -39.2 | -55.1 | -47.3 | 6.77 | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 6.77 | -55.1 | -14.1 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
REGENXBIO
RGNX
|
-5.22 | $ 7.66 | -5.08 % | $ 395 M |  USA |
 |
Rigel Pharmaceuticals
RIGL
|
5.31 | $ 43.83 | 4.22 % | $ 788 M | USA |
 |
SELLAS Life Sciences Group
SLS
|
-17.8 | $ 8.38 | -2.39 % | $ 914 M | USA |
 |
Celsion Corporation
CLSN
|
0.248 | - | -6.63 % | $ 13.9 M | USA |
 |
I-Mab
IMAB
|
-37.7 | - | - | $ 866 M |  China |
 |
Tenax Therapeutics
TENX
|
-8.49 | $ 1.69 | -5.34 % | $ 66.3 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
50.9 K | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
-12.1 | - | -13.47 % | $ 169 M | France |
 |
CureVac N.V.
CVAC
|
-2.11 | - | - | $ 867 M |  Germany |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
8.55 | - | 0.74 % | $ 768 M |  Israel |
 |
Abcam plc
ABCM
|
-513 | - | - | $ 4.9 B |  Britain |
 |
Rezolute
RZLT
|
-4.95 | $ 4.01 | 3.83 % | $ 417 M | USA |
 |
Midatech Pharma plc
MTP
|
0.204 | - | -18.52 % | $ 27.3 M | Britain |
 |
Tiziana Life Sciences PLC
TLSA
|
-6.58 | $ 0.61 | -8.44 % | $ 65.1 M | Britain |
 |
MorphoSys AG
MOR
|
-9.67 | - | 2.43 % | $ 254 M | Germany |
 |
Affimed N.V.
AFMD
|
0.361 | - | -34.95 % | $ 21.5 M | Germany |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
-2.15 | - | -1.58 % | $ 28.1 M | China |
 |
Celyad Oncology SA
CYAD
|
0.0447 | - | - | $ 12.5 M |  Belgium |
 |
Seer
SEER
|
0.144 | $ 1.62 | -3.57 % | $ 89.7 M | USA |
 |
Gracell Biotechnologies
GRCL
|
2.07 | - | - | $ 3.37 B | China |
 |
Shattuck Labs
STTK
|
-6.35 | $ 4.86 | -2.71 % | $ 338 M | USA |
|
Silence Therapeutics plc
SLN
|
-48.1 | $ 19.78 | 0.15 % | $ 2.8 B | Britain |
 |
Stoke Therapeutics
STOK
|
-106 | $ 27.16 | -1.98 % | $ 1.61 B | USA |
 |
Sutro Biopharma
STRO
|
-2.84 | $ 10.08 | -5.0 % | $ 85.7 M | USA |
 |
Soligenix
SNGX
|
-0.18 | $ 0.32 | -6.35 % | $ 1.66 M | USA |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
22.4 | $ 42.54 | -1.0 % | $ 48.7 B | Israel |
 |
China SXT Pharmaceuticals
SXTC
|
3.12 | $ 2.99 | -3.55 % | $ 2.03 M | China |
 |
Spruce Biosciences
SPRB
|
-0.252 | $ 46.36 | -6.04 % | $ 35.5 M | USA |
 |
Takeda Pharmaceutical Company Limited
TAK
|
20.3 | $ 20.9 | -0.9 % | $ 33 B |  Japan |
 |
Supernus Pharmaceuticals
SUPN
|
115 | $ 28.77 | 4.15 % | $ 1.62 B | USA |
 |
Galapagos NV
GLPG
|
5.67 | - | - | $ 1.83 B | Belgium |
 |
Savara
SVRA
|
-9.6 | $ 4.92 | -2.57 % | $ 1.09 B | USA |
 |
Teligent, Inc.
TLGT
|
2.8 | - | -13.85 % | $ 16.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
-1.96 | - | - | $ 2.91 B | USA |
 |
TG Therapeutics
TGTX
|
37.9 | $ 64.27 | 1.4 % | $ 9.28 B | USA |
 |
Aphria Inc.
APHA
|
-117 | - | -0.45 % | $ 4.87 B |  Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
-3.41 | - | -0.90 % | $ 104 M | USA |
 |
Chiasma, Inc.
CHMA
|
-2.73 | - | -6.00 % | $ 238 M | USA |
 |
Trevi Therapeutics
TRVI
|
-30.5 | $ 14.92 | -2.55 % | $ 2.01 B | USA |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
-5.12 | - | - | $ 376 M | USA |
 |
Cellect Biotechnology Ltd.
APOP
|
27.1 | - | 0.38 % | $ 12.9 M | Israel |
 |
AzurRx BioPharma, Inc.
AZRX
|
-0.000002 | - | 2.07 % | $ 34.4 M | USA |
 |
Cerecor Inc.
CERC
|
-4.65 | - | -1.68 % | $ 283 M | USA |
 |
Constellation Pharmaceuticals, Inc.
CNST
|
-11.6 | - | - | $ 1.63 B | USA |
 |
Auris Medical Holding Ltd.
EARS
|
0.463 | - | -1.77 % | $ 39.2 M |  Bermuda |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
-14.4 | - | 0.34 % | $ 2.98 B | USA |
 |
ERYTECH Pharma S.A.
ERYP
|
5.22 | - | 1.3 % | $ 27.7 M | France |